United Therapeutics Corporation

UTHR·NASDAQ·$578.43Share Price as of 11/2·$25BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/05/26 10-QQ1 ended 03/31/2605/06/26 10-KFY 202502/25/26 10-QQ3 ended 09/30/2510/29/25 10-QQ2 ended 06/30/2507/30/25

Disclosures

8-KCurrent report10/22/26 8-KCurrent report10/14/26 8-KCurrent report09/08/26 8-KCurrent report08/05/26 8-KCurrent report07/23/26

Prospectuses and Registrations

S-8Registration of securities for employees07/13/26 S-8 POSPost-effective amendment (S-8)07/13/26 S-8 POSPost-effective amendment (S-8)07/13/26 S-8 POSPost-effective amendment (S-8)07/13/26 S-8 POSPost-effective amendment (S-8)07/13/26

Proxies

DEF 14ADefinitive proxy04/29/26 DEFA14AAdditional proxy materials04/29/26 DEF 14ADefinitive proxy04/29/25 DEFA14AAdditional proxy materials04/29/25 DEF 14ADefinitive proxy04/29/24

Ownership

Form 4Insider transaction10/30/26 Form 4Insider transaction10/29/26 Form 4Insider transaction10/28/26 Form 4Insider transaction10/27/26 Form 4Insider transaction10/26/26

Other

SDConflict Minerals disclosure06/02/26 ARSAnnual report to shareholders04/29/26 SDConflict Minerals disclosure05/30/25 ARSAnnual report to shareholders04/29/25 SDConflict Minerals disclosure05/31/24